Nothing Special   »   [go: up one dir, main page]

DK159191A - Farmaceutiske praeparater - Google Patents

Farmaceutiske praeparater Download PDF

Info

Publication number
DK159191A
DK159191A DK159191A DK159191A DK159191A DK 159191 A DK159191 A DK 159191A DK 159191 A DK159191 A DK 159191A DK 159191 A DK159191 A DK 159191A DK 159191 A DK159191 A DK 159191A
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparations
salt
bismuth
ethenediamine
propanetricarboxylate
Prior art date
Application number
DK159191A
Other languages
Danish (da)
English (en)
Other versions
DK159191D0 (da
Inventor
Norman Richard Smith
Colin Roy Heppenstall
Stephen John Douglas
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DK159191D0 publication Critical patent/DK159191D0/da
Publication of DK159191A publication Critical patent/DK159191A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/245Bismuth; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Saccharide Compounds (AREA)
DK159191A 1990-09-11 1991-09-10 Farmaceutiske praeparater DK159191A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909019875A GB9019875D0 (en) 1990-09-11 1990-09-11 Pharmaceutical compositions
NO920408A NO179694C (no) 1990-09-11 1992-01-30 Farmasöytiske preparater inneholdende ranitidinderivater
PCT/EP1992/000498 WO1993017679A1 (en) 1990-09-11 1992-03-05 Compositions containing ranitidine/bismuth carboxylates salts

Publications (2)

Publication Number Publication Date
DK159191D0 DK159191D0 (da) 1991-09-10
DK159191A true DK159191A (da) 1992-03-12

Family

ID=47884627

Family Applications (1)

Application Number Title Priority Date Filing Date
DK159191A DK159191A (da) 1990-09-11 1991-09-10 Farmaceutiske praeparater

Country Status (33)

Country Link
US (1) US5456925A (xx)
EP (1) EP0558779B1 (xx)
JP (1) JPH0692849A (xx)
KR (1) KR100196308B1 (xx)
AT (2) AT405134B (xx)
AU (2) AU640816B2 (xx)
BE (1) BE1005115A5 (xx)
BG (1) BG61931B1 (xx)
CA (1) CA2050970C (xx)
CH (1) CH683068A5 (xx)
CY (1) CY1988A (xx)
DE (2) DE4130061A1 (xx)
DK (1) DK159191A (xx)
ES (1) ES2072647T3 (xx)
FI (1) FI944047A0 (xx)
FR (1) FR2666508B1 (xx)
GB (2) GB9019875D0 (xx)
HK (1) HK60894A (xx)
HU (1) HU211846A9 (xx)
IE (1) IE65049B1 (xx)
IL (1) IL99428A (xx)
IT (1) IT1249696B (xx)
MX (1) MX9101009A (xx)
NL (1) NL194907C (xx)
NO (1) NO179694C (xx)
NZ (1) NZ239731A (xx)
OA (1) OA10093A (xx)
RO (1) RO112084B1 (xx)
RU (1) RU2108097C1 (xx)
SE (1) SE509694C2 (xx)
SK (1) SK279591B6 (xx)
WO (1) WO1993017679A1 (xx)
ZA (1) ZA917176B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
DE69228738D1 (de) * 1991-12-06 1999-04-29 Glaxo Group Ltd Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
EP0805815B1 (en) * 1995-01-26 2002-04-10 Nycomed Imaging A/S Use of bismuth compounds for the manufacture of medicaments for the treatment of gastric disorders caused by Helicobacter pylori
GB9501560D0 (en) * 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
WO2000010562A1 (fr) * 1998-08-18 2000-03-02 Leonidov Nikolai B Forme physiquement stable et amorphe aux rayons x de ranitidine d'hydrochlorure ayant une action anti-ulcere accrue, et procede de production
EP1104673A1 (en) * 1999-11-30 2001-06-06 Bayer Classics A hydrogen carbonate-containing, desintegrating agent-free pharmaceutical composition
KR100412290B1 (ko) * 2001-11-27 2003-12-31 주식회사 동구제약 라니티딘 함유 현탁제 조성물 및 그의 제조방법
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
BRPI0916344A2 (pt) 2008-07-21 2020-07-21 Albemarle Corporation grânulos com alto teor de ibuprofeno de sódio, preparação e utilização para preparação de formas de dosagem sólidas não efervescentes
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
WO2021244481A1 (en) * 2020-06-01 2021-12-09 The University Of Hong Kong Compositions and methods for treating a sars-cov-2 infection

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608257A (en) * 1984-01-03 1986-08-26 Board Of Regents For Oklahoma State University Composition and method for treating heat stress
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
EP0282132B1 (en) * 1987-03-09 1992-09-30 The Procter & Gamble Company Compositions and their use for treating gastrointestinal disorders
DE3710462A1 (de) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
FR2633181B1 (fr) * 1988-06-24 1992-01-10 Glaxo Lab Sa Composition pharmaceutique a base de ranitidine et son procede de preparation
CH679582A5 (xx) * 1988-07-18 1992-03-13 Glaxo Group Ltd
ES2040307T3 (es) * 1988-10-08 1993-10-16 Dr. R. Pfleger Chemische Fabrik Gmbh Procedimiento para producir un preparado medicamentoso liquido que contiene bismuto.
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
US5013560A (en) * 1989-03-17 1991-05-07 The Procter & Gamble Company Microbially-stable bismuth-containing liquid pharmaceutical suspensions
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
ATE122883T1 (de) 1995-06-15
NO179694C (no) 1996-12-04
CA2050970C (en) 2002-11-19
ITRM910673A1 (it) 1993-03-10
KR920005984A (ko) 1992-04-27
IL99428A0 (en) 1992-08-18
NL194907B (nl) 2003-03-03
SE9102604L (sv) 1992-03-12
WO1993017679A1 (en) 1993-09-16
HK60894A (en) 1994-07-08
CA2050970A1 (en) 1992-03-12
IE65049B1 (en) 1995-10-04
SK279591B6 (sk) 1999-01-11
SK106094A3 (en) 1995-02-08
AU640816B2 (en) 1993-09-02
CH683068A5 (fr) 1994-01-14
ES2072647T3 (es) 1995-07-16
GB9019875D0 (en) 1990-10-24
RU2108097C1 (ru) 1998-04-10
ATA180191A (de) 1998-10-15
MX9101009A (es) 1992-05-04
OA10093A (en) 1996-12-18
KR100196308B1 (ko) 1999-06-15
SE509694C2 (sv) 1999-02-22
EP0558779A1 (en) 1993-09-08
NL194907C (nl) 2003-07-04
FR2666508B1 (fr) 1994-02-18
GB9119284D0 (en) 1991-10-23
NL9101533A (nl) 1992-04-01
FI944047A (fi) 1994-09-02
NO920408D0 (no) 1992-01-30
JPH0692849A (ja) 1994-04-05
AT405134B (de) 1999-05-25
AU1334792A (en) 1993-10-05
NO179694B (no) 1996-08-26
ZA917176B (en) 1992-06-24
EP0558779B1 (en) 1995-05-24
DE69202696D1 (de) 1995-06-29
IL99428A (en) 1996-06-18
NO920408L (no) 1993-08-02
DK159191D0 (da) 1991-09-10
FI944047A0 (fi) 1994-09-02
NZ239731A (en) 1993-10-26
ITRM910673A0 (it) 1991-09-10
AU8375791A (en) 1992-03-19
GB2248185B (en) 1994-02-02
BE1005115A5 (fr) 1993-04-27
BG99021A (bg) 1995-06-30
GB2248185A (en) 1992-04-01
SE9102604D0 (sv) 1991-09-10
BG61931B1 (bg) 1998-10-30
DE4130061A1 (de) 1992-03-12
FR2666508A1 (fr) 1992-03-13
IT1249696B (it) 1995-03-09
RO112084B1 (ro) 1997-05-30
CY1988A (en) 1997-09-05
US5456925A (en) 1995-10-10
IE913191A1 (en) 1992-04-22
HU211846A9 (en) 1995-12-28

Similar Documents

Publication Publication Date Title
DK159191D0 (da) Farmaceutiske praeparater
DE3689246D1 (de) Physiologisch aktives Polypeptid BUF-3.
DK585886D0 (da) Immunstimulerende middel og anvendelse deraf
ES2058651T3 (es) Uso derivados de guanidina para la fabricacion de un medicamento con actividad antagonista de npy.
IT8722481A0 (it) Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse.
TR24895A (tr) PIRIMIDIN TüREVLERI,BUNLARIN ISTIHSAL EDILMESI VE KULLANILMASI
DK403789A (da) Et nyt antibiotikum, mersacidin, dets fremstilling og anvendelse som laegemiddel
ATE104554T1 (de) Topische praeparate.
DE3876425D1 (de) Gesteuerte verabreichung eines heilmittels an blut.
DE3869156D1 (de) Fungizide 2-anilinthiazoline.
TR25156A (tr) YENI FUNGISID TESIRLI ASILAMINOBENZAMIDLER, BUNLARIN HAZIRLANMASI ICIN ISLEMLER VE BUNLARIN BITKILERIN MANTAR ENFEKSIYONLARYLA MüCADELEDE KULLANIMI.
DE3865642D1 (de) Pharmazeutische zubereitung zur cholelitholyse.
NO873385D0 (no) Oksiran-pseudooligosakkarider, fremgangsmaate til deres fremstilling, deres anvendelse og farmasoeytiske preparater.
MX9203658A (es) Derivados de piridobenzoxazina opticamente activos, y su uso antimicrobiano.
GB2162746A (en) Antiacidotic medicinal agent
FR2191842A2 (en) Insecticidal compsns contg thiapyrans - 4-(4'-methyl-3'-hexenyl) 5,6-dihydro-2-H-thiapyran and its 5-oxide have juvenile hormone activity

Legal Events

Date Code Title Description
PUP Patent expired
AHB Application shelved due to non-payment